370 Clinical Trials for: SEARCH[STUDY] MK-3475, Page 1 of 19

Hide Studies Not Seeking New Volunteers


A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037/ ECHO-202)

Condition(s): Malignant Solid Tumor; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Non-Small-Cell Lung; Transitional Cell Carcinoma of Urinary Tract; Triple Negative Breast Cancer; Carcinoma, Squamous Cell of Head and Neck; Ovarian Neoplasms; Adenocarcinoma of the Endometrium; Renal Cell Carcinoma; Microsatellite-instability (MSI) High Colorectal Cancer Last Updated: October 3, 2016Recruiting